How GLP-1s helped a Rhode Island mom get sober after battling alcoholism – WBUR

Report on the Use of GLP-1 Drugs in Addiction Treatment at Open Doors Transitional Home

Introduction

In recent years, GLP-1 drugs such as Wegovy and Mounjaro, primarily known for weight loss, have garnered attention for their potential in treating cravings associated with addictive substances including drugs and alcohol. While further research is necessary, some addiction specialists have begun prescribing these medications as adjuncts to behavioral and lifestyle interventions.

Pilot Program Overview at Open Doors Transitional Home

The Open Doors transitional home, a non-profit organization based in Rhode Island, has initiated a pilot program offering GLP-1 drugs to 18 residents. This initiative aligns with several Sustainable Development Goals (SDGs), particularly:

• SDG 3: Good Health and Well-being – by promoting recovery and reducing substance addiction.
• SDG 10: Reduced Inequalities – by providing equitable access to innovative treatment for vulnerable populations.

Residents report that the combination of GLP-1 treatments and comprehensive support services has significantly improved their lives.

Case Study: Gina Roberts

One notable beneficiary is Gina Roberts, a Rhode Island mother who struggled with alcoholism for years. Her addiction led to the loss of custody of her son. After participating in the GLP-1 treatment program, Roberts reports:

1. Complete cessation of cravings.
2. Two years of sustained sobriety.
3. Securing independent housing.
4. Regaining custody of her son.

This personal transformation highlights the program’s contribution to SDG 1: No Poverty and SDG 5: Gender Equality, by empowering women to rebuild their families and lives.

Collaborations and Expert Involvement

The pilot program is a collaborative effort involving:

• Open Doors transitional home
• Steven Klein, addiction medicine specialist from the Caron Treatment Center, Pennsylvania
• Center for Addiction Science, Policy and Research

These partnerships enhance the program’s capacity to address addiction through integrated medical and behavioral approaches, supporting SDG 17: Partnerships for the Goals.

Conclusion

The pilot initiative at Open Doors demonstrates promising outcomes in addiction treatment through the use of GLP-1 drugs combined with supportive services. This approach contributes to multiple Sustainable Development Goals by improving health, reducing inequalities, and fostering partnerships. Continued research and expansion of such programs could further advance global efforts toward sustainable health and well-being.

1. Sustainable Development Goals (SDGs) Addressed

1. SDG 3: Good Health and Well-being
   • The article focuses on addiction treatment, recovery, and improving health outcomes through innovative medical treatments (GLP-1 drugs) combined with behavioral support.
2. SDG 10: Reduced Inequalities
   • The program targets vulnerable populations, including individuals recovering from addiction and those affected by social challenges such as foster care, aiming to reduce health disparities.
3. SDG 1: No Poverty
   • By supporting individuals to regain stability, housing, and custody of children, the program indirectly addresses poverty alleviation and social reintegration.

2. Specific Targets Under the Identified SDGs

1. SDG 3: Good Health and Well-being
   • Target 3.5: Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.
   • Target 3.4: Reduce premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
2. SDG 10: Reduced Inequalities
   • Target 10.2: Empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status.
3. SDG 1: No Poverty
   • Target 1.4: Ensure that all men and women, particularly the poor and vulnerable, have equal rights to economic resources, as well as access to basic services, ownership and control over land and other forms of property.

3. Indicators Mentioned or Implied in the Article

1. Indicators for SDG 3 Targets:
   • Prevalence of substance use disorders among the population served.
   • Number or percentage of individuals receiving treatment for substance abuse.
   • Rate of sustained sobriety or relapse rates post-treatment (e.g., Gina Roberts being sober for two years).
   • Access to and use of innovative treatment methods such as GLP-1 drugs.
2. Indicators for SDG 10 Target:
   • Number of individuals from marginalized groups gaining access to addiction treatment and social services.
   • Measures of social inclusion such as regaining custody of children or stable housing.
3. Indicators for SDG 1 Target:
   • Number of individuals moving from unstable to stable housing or economic conditions.
   • Access to basic services and support programs for vulnerable populations.

4. Table of SDGs, Targets, and Indicators

Source: wbur.org